Since our previous work determined that vitamin D signaling is compromised in KRAS-mutant models of NSCLC, lack of association between 25(OH)D3 and PFS in this subset of patients was not unexpected [19]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.